Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Ryberg, N. Larsson, S. Sjögren, S. Hjorth, Nils-Olov Hermansson, J. Leonova, T. Elebring, K. Nilsson, T. Drmota, P. Greasley (2007)
The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 152
W. Veling, J. Mackenbach, J. os, H. Hoek (2008)
Cannabis use and genetic predisposition for schizophrenia: a case-control studyPsychological Medicine, 38
S. Anavi-Goffer, G. Baillie, A. Irving, J. Gertsch, I. Greig, R. Pertwee, R. Ross (2011)
Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids*The Journal of Biological Chemistry, 287
J. Houston, Jamie Murphy, M. Shevlin, G. Adamson (2011)
Cannabis use and psychosis: re-visiting the role of childhood traumaPsychological Medicine, 41
R. Winkel (2011)
Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-upArchives of General Psychiatry, 68
S. Broyd, L. Greenwood, R. Croft, Anna Dalecki, J. Todd, P. Michie, S. Johnstone, N. Solowij (2013)
Chronic effects of cannabis on sensory gating.International journal of psychophysiology : official journal of the International Organization of Psychophysiology, 89 3
B. Gutiérrez, Margarita Rivera, Lourdes Obel, Kathryn McKenney, Rafael Martínez-Leal, Esther Molina, M. Dolz, Susana Ochoa, Judit Usall, Josep Haro, M. Ruiz-Veguilla, F. Torres, J. Cervilla (2009)
Variabilidad en el gen COMT y modificación del riesgo de esquizofrenia conferido por consumo de cannabisRevista de Psiquiatría y Salud Mental, 2
C. Hollis, M. Groom, D. Das, T. Calton, A. Bates, H. Andrews, G. Jackson, P. Liddle (2008)
Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD)Schizophrenia Research, 105
R. Mizrahi, I. Suridjan, M. Kenk, T. George, Alan Wilson, S. Houle, P. Rusjan (2013)
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNONeuropsychopharmacology, 38
L. Duncan, M. Keller (2011)
A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry.The American journal of psychiatry, 168 10
S. Borgwardt, P. Allen, S. Bhattacharyya, P. Fusar-Poli, J. Crippa, M. Seal, V. Fraccaro, Z. Atakan, R. Martín-Santos, C. O’Carroll, K. Rubia, P. McGuire (2008)
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response InhibitionBiological Psychiatry, 64
C. Henquet, R. Murray, D. Linszen, J. os (2005)
The environment and schizophrenia: the role of cannabis use.Schizophrenia bulletin, 31 3
P. Morrison, R. Murray (2009)
From real-world events to psychosis: the emerging neuropharmacology of delusions.Schizophrenia bulletin, 35 4
S. Zammit, M. Owen, J. Evans, J. Heron, G. Lewis (2011)
Cannabis, COMT and psychotic experiencesBritish Journal of Psychiatry, 199
J. Littleton, K. Maclean, G. Brownlee (1976)
Proceedings: Alterations in dopamine uptake in rat corpus striatum induced by combinations of stress and delta8-tetrahydrocannabinol (delta8-THC).British journal of pharmacology, 56 3
R. Pertwee (1997)
Pharmacology of cannabinoid CB1 and CB2 receptors.Pharmacology & therapeutics, 74 2
S. Bhattacharyya, J. Crippa, P. Allen, R. Martín-Santos, S. Borgwardt, P. Fusar-Poli, K. Rubia, J. Kambeitz, C. O’Carroll, M. Seal, V. Giampietro, M. Brammer, A. Zuardi, Z. Atakan, P. McGuire (2012)
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.Archives of general psychiatry, 69 1
N. Wegener, M. Koch (2009)
Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatmentBrain Research, 1253
N. Solowij, R. Stephens, R. Roffman, T. Babor, R. Kadden, Michael Miller, K. Christiansen, B. McRee, J. Vendetti (2002)
Cognitive functioning of long-term heavy cannabis users seeking treatment.JAMA, 287 9
A. Caspi, T. Moffitt, M. Cannon, J. McClay, R. Murray, H. Harrington, Alan Taylor, L. Arseneault, B. Williams, A. Braithwaite, R. Poulton, I. Craig (2005)
Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment InteractionBiological Psychiatry, 57
C. Morgan, C. Gardener, G. Schafer, S. Swan, C. Demarchi, T. Freeman, P. Warrington, I. Rupasinghe, A. Ramoutar, N. Tan, G Wingham, S. Lewis, H. Curran (2011)
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-beingPsychological Medicine, 42
J. Houston, Jamie Murphy, G. Adamson, M. Stringer, M. Shevlin (2007)
Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey.Schizophrenia bulletin, 34 3
D. Fergusson, L. Horwood, N. Swain-Campbell (2003)
Cannabis dependence and psychotic symptoms in young peoplePsychological Medicine, 33
P. Fusar-Poli, J. Crippa, S. Bhattacharyya, S. Borgwardt, P. Allen, R. Martín-Santos, M. Seal, S. Surguladze, Colin O'Carrol, Z. Atakan, A. Zuardi, P. McGuire (2009)
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.Archives of general psychiatry, 66 1
MD Kahn, MD Linszen, MD Bruggeman (2011)
Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis - an analysis of patient-sibling and sibling-control pairs
M. Ranganathan, D. D’Souza (2006)
The acute effects of cannabinoids on memory in humans: a reviewPsychopharmacology, 188
A. Howlett, P. Reggio, S. Childers, R. Hampson, Nadine Ulloa, D. Deutsch (2011)
Endocannabinoid tone versus constitutive activity of cannabinoid receptorsBritish Journal of Pharmacology, 163
O. Howes, J. Kambeitz, Euitae Kim, D. Ståhl, M. Slifstein, A. Abi-Dargham, S. Kapur (2012)
The nature of dopamine dysfunction in schizophrenia and what this means for treatment.Archives of general psychiatry, 69 8
P. Morrison, J. Stone (2011)
Synthetic delta‐9‐tetrahydrocannabinol elicits schizophrenia‐like negative symptoms which are distinct from sedationHuman Psychopharmacology: Clinical and Experimental, 26
J. Pelayo-Terán, R. Perez-Iglesias, I. Mata, E. Carrasco-Marín, J. Vázquez-Barquero, B. Crespo-Facorro (2010)
Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: Clinical-onset implicationsPsychiatry Research, 179
J. Os, R. Linscott, I. Myin-Germeys, P. Delespaul, L. Krabbendam (2008)
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorderPsychological Medicine, 39
M. Konings, N. Stefanis, R. Kuepper, R. Graaf, M. Have, J. Os, C. Bakoula, C. Henquet (2011)
Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis riskPsychological Medicine, 42
S. Bhattacharyya, P. Morrison, P. Fusar-Poli, R. Martín-Santos, S. Borgwardt, T. Winton-Brown, C. Nosarti, C. Carroll, M. Seal, P. Allen, M. Mehta, J. Stone, N. Tunstall, V. Giampietro, S. Kapur, R. Murray, A. Zuardi, J. Crippa, Z. Atakan, P. McGuire (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and PsychopathologyNeuropsychopharmacology, 35
N. Urban, M. Slifstein, Judy Thompson, Xiaoyan Xu, R. Girgis, S. Raheja, M. Haney, A. Abi-Dargham (2012)
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography StudyBiological Psychiatry, 71
R. Kuepper, J. Ceccarini, J. Lataster, J. os, M. Kroonenburgh, J. Gerven, M. Marcelis, K. Laere, C. Henquet (2013)
Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography StudyPLoS ONE, 8
H. Pope, A. Gruber, J. Hudson, Geoffrey Cohane, M. Huestis, D. Yurgelun-Todd (2003)
Early-onset cannabis use and cognitive deficits: what is the nature of the association?Drug and alcohol dependence, 69 3
P. Castillo, Thomas Younts, A. Chávez, Y. Hashimotodani (2012)
Endocannabinoid Signaling and Synaptic FunctionNeuron, 76
J. Mcgrath, J. Welham, James Scott, D. Varghese, L. Degenhardt, M. Hayatbakhsh, R. Alati, Gail Williams, W. Bor, J. Najman (2010)
Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults.Archives of general psychiatry, 67 5
M. Dominguez, M. Wichers, R. Lieb, R. Lieb, H. Wittchen, H. Wittchen, J. Os (2011)
Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study.Schizophrenia bulletin, 37 1
M. Forti, C. Iyegbe, H. Sallis, A. Kolliakou, M. Falcone, A. Paparelli, M. Sirianni, C. Cascia, S. Stilo, T. Marques, R. Handley, V. Mondelli, P. Dazzan, C. Pariante, A. David, C. Morgan, J. Powell, R. Murray (2012)
Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis UsersBiological Psychiatry, 72
T. Ohno-Shosaku, A. Tanimura, Y. Hashimotodani, M. Kano (2012)
Endocannabinoids and Retrograde Modulation of Synaptic TransmissionThe Neuroscientist, 18
R. Kuepper, P. Morrison, J. Os, R. Murray, G. Kenis, C. Henquet (2010)
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplinesSchizophrenia Research, 121
P. Habets, M. Marcelis, E. Gronenschild, M. Drukker, J. Os (2011)
Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in SchizophreniaBiological Psychiatry, 69
P. Fusar-Poli, P. Allen, S. Bhattacharyya, J. Crippa, A. Mechelli, S. Borgwardt, R. Martín-Santos, M. Seal, Colin O'Carrol, Z. Atakan, A. Zuardi, P. McGuire (2010)
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.The international journal of neuropsychopharmacology, 13 4
M. Konings, C. Henquet, H. Maharajh, G. Hutchinson, J. Os (2008)
Early exposure to cannabis and risk for psychosis in young adolescents in TrinidadActa Psychiatrica Scandinavica, 118
Rachel Rabin, K. Zakzanis, T. George (2011)
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysisSchizophrenia Research, 128
R. Martín-Santos, A. Fagundo, J. Crippa, Z. Atakan, S. Bhattacharyya, P. Allen, P. Fusar-Poli, S. Borgwardt, M. Seal, G. Busatto, P. McGuire (2009)
Neuroimaging in cannabis use: a systematic review of the literaturePsychological Medicine, 40
P. Stokes, A. Egerton, B. Watson, A. Reid, J. Lappin, O. Howes, D. Nutt, A. Lingford-Hughes (2012)
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availabilityJournal of Psychopharmacology, 26
A. Batalla, C. Soriano-Mas, M. López-Solà, M. Torrens, J. Crippa, S. Bhattacharyya, L. Blanco-Hinojo, A. Fagundo, B. Harrison, S. Nogué, R. Torre, M. Farré, J. Pujol, R. Martín-Santos (2014)
Modulation of brain structure by catechol‐O‐methyltransferase Val158Met polymorphism in chronic cannabis usersAddiction Biology, 19
M. Pistis, S. Perra, G. Pillolla, M. Melis, A. Muntoni, G. Gessa (2004)
Adolescent exposure to cannabinoids induces long-Lasting changes in the response to drugs of abuse of rat midbrain dopamine neuronsBiological Psychiatry, 56
L. Voruganti, P. Slomka, P. Zabel, Adel Mattar, A. Awad (2001)
Cannabis induced dopamine release: an in-vivo SPECT studyPsychiatry Research: Neuroimaging, 107
T. Winton-Brown, P. Allen, Sagnik Bhattacharrya, S. Borgwardt, P. Fusar-Poli, J. Crippa, M. Seal, R. Martín-Santos, D. Ffytche, A. Zuardi, Z. Atakan, P. McGuire (2010)
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI StudyNeuropsychopharmacology, 36
N. Solowij, M. Walterfang, D. Lubman, S. Whittle, V. Lorenzetti, M. Styner, D. Velakoulis, C. Pantelis, M. Yücel (2010)
Alteration to hippocampal shape in cannabis users with and without schizophreniaSchizophrenia Research, 143
M. Bossong, B. Berckel, R. Boellaard, L. Zuurman, R. Schuit, A. Windhorst, J. Gerven, N. Ramsey, A. Lammertsma, R. Kahn (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human StriatumNeuropsychopharmacology, 34
W. Hall, N. Solowij (1998)
Adverse effects of cannabisThe Lancet, 352
G. Estrada, M. Fatjó-Vilas, M. Muñoz, G. Pulido, M. Miñano, E. Toledo, J. Illa, M. Martín, M. Miralles, S. Miret, S. Campanera, Carmelo Bernabeu, M. Navarro, L. Fañanás (2011)
Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphismActa Psychiatrica Scandinavica, 123
D. Mokler, S. Robinson, J. Johnson, J. Hong, J. Rosecrans (1987)
Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat.Neurotoxicology and teratology, 9 4
Joshua Kantrowitz, K. Nolan, S. Sen, A. Simen, H. Lachman, M. Bowers (2009)
Adolescent Cannabis Use, Psychosis and Catechol-O-Methyltransferase Genotype in African Americans and CaucasiansPsychiatric Quarterly, 80
Vivien Chevaleyre, Kanji Takahashi, P. Castillo (2006)
Endocannabinoid-mediated synaptic plasticity in the CNS.Annual review of neuroscience, 29
S. Zammit, G. Spurlock, H. Williams, N. Norton, N. Williams, M. O’Donovan, M. Owen (2007)
Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis useBritish Journal of Psychiatry, 191
M. Schneider, E. Drews, M. Koch (2005)
Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2Behavioural Pharmacology, 16
N. Solowij, R. Battisti (2008)
The chronic effects of cannabis on memory in humans: a review.Current drug abuse reviews, 1 1
R. Battisti, S. Roodenrys, S. Johnstone, Nicole Pesa, D. Hermens, N. Solowij (2010)
Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolutionPsychopharmacology, 212
C. Morgan, H. Curran (2008)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabisBritish Journal of Psychiatry, 192
J. Costas, J. Sanjuán, R. Ramos‐Ríos, Eduardo Paz, S. Agra, A. Tolosa, M. Páramo, J. Brenlla, M. Arrojo (2011)
Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from SpainSchizophrenia Research, 127
Marie-Anne Khoury, V. Gorgievski, Larissa Moutsimilli, B. Giros, E. Tzavara (2012)
Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studiesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 38
Á. Behan, Magdalena Hryniewiecka, C. O’Tuathaigh, A. Kinsella, M. Cannon, M. Karayiorgou, J. Gogos, J. Waddington, D. Cotter (2012)
Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic PathwaysNeuropsychopharmacology, 37
J. Smoller, K. Kendler, N. Craddock, Phil Lee, B. Neale, J. Nurnberger, S. Ripke, S. Santangelo, P. Sullivan, S. Purcell, R. Anney, J. Buitelaar, A. Fanous, S. Faraone, W. Hoogendijk, K. Lesch, D. Levinson, R. Perlis, M. Rietschel, B. Riley, E. Sonuga-Barke, R. Schachar, T. Schulze, A. Thapar, M. Neale, Patrick Bender, S. Cichon, M. Daly, J. Kelsoe, T. Lehner, M. O’Donovan, P. Gejman, J. Sebat, P. Sklar (2013)
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysisThe Lancet, 381
C. Henquet, L. Krabbendam, J. Spauwen, Charles Kaplan, R. Lieb, H. Wittchen, J. os (2004)
P.3.a.031 Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young peopleEuropean Neuropsychopharmacology, 16
D. D’Souza, E. Perry, L. Macdougall, Yola Ammerman, T. Cooper, Yu-Te Wu, Gabriel Braley, R. Gueorguieva, J. Krystal (2004)
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisNeuropsychopharmacology, 29
C. Vinkers, W. Gastel, C. Schubart, K. Eijk, J. Luykx, R. Winkel, M. Joëls, R. Ophoff, M. Boks, R. Bruggeman, W. Cahn, L. Haan, R. Kahn, C. Meijer, I. Myin-Germeys, J. Os, D. Wiersma (2013)
The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val158Met polymorphismSchizophrenia Research, 150
R. Kuepper, J. os, R. Lieb, H. Wittchen, M. Höfler, C. Henquet (2011)
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort studyThe BMJ, 342
N. Realini, T. Rubino, D. Parolaro (2009)
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.Pharmacological research, 60 2
M. Meier, A. Caspi, Antony Ambler, H. Harrington, R. Houts, R. Keefe, Kay McDonald, Aimee Ward, R. Poulton, T. Moffitt (2012)
Persistent cannabis users show neuropsychological decline from childhood to midlifeProceedings of the National Academy of Sciences, 109
Celia Morgan, Gra´inne, Tom Schafer, Freeman Valerie, Curran (2010)
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic studyBritish Journal of Psychiatry, 197
R. Winkel, N. Beveren, C. Simons (2011)
AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic DisorderNeuropsychopharmacology, 36
M. Harley, I. Kelleher, M. Clarke, F. Lynch, L. Arseneault, D. Connor, C. Fitzpatrick, M. Cannon (2009)
Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescencePsychological Medicine, 40
A. Cougnard, M. Marcelis, I. Myin-Germeys, R. Graaf, W. Vollebergh, L. Krabbendam, R. Lieb, H. Wittchen, C. Henquet, J. Spauwen, J. os (2007)
Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness–persistence modelPsychological Medicine, 37
A. Bacci, J. Huguenard, D. Prince (2004)
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoidsNature, 431
Jamie Murphy, J. Houston, M. Shevlin, G. Adamson (2013)
Childhood sexual trauma, cannabis use and psychosis: statistically controlling for pre-trauma psychosis and psychopathologySocial Psychiatry and Psychiatric Epidemiology, 48
Matthew Smith, D. Barch, T. Wolf, D. Mamah, J. Csernansky (2008)
Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophreniaSchizophrenia Research, 106
P. Morrison, V. Zois, D. McKeown, Tak Lee, D. Holt, J. Powell, S. Kapur, R. Murray (2009)
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioningPsychological Medicine, 39
C. Henquet, A. Rosa, L. Krabbendam, S. Papiol, L. Fañanás, M. Drukker, J. Ramaekers, J. Os (2006)
An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and CognitionNeuropsychopharmacology, 31
P. Stokes, A. Egerton, B. Watson, A. Reid, G. Breen, A. Lingford-Hughes, D. Nutt, M. Mehta (2010)
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challengeNeuroImage, 52
R. Ferdinand, F. Sondeijker, J. Ende, J. Selten, A. Huizink, F. Verhulst (2005)
Cannabis use predicts future psychotic symptoms, and vice versa.Addiction, 100 5
R. Winkel, G. Esquivel, G. Kenis, M. Wichers, D. Collip, O. Peerbooms, B. Rutten, I. Myin-Germeys, J. os (2010)
REVIEW: Genome‐Wide Findings in Schizophrenia and the Role of Gene–Environment InterplayCNS Neuroscience & Therapeutics, 16
T. Demirakca, A. Sartorius, G. Ende, N. Meyer, Helga Welzel, G. Skopp, K. Mann, D. Hermann (2010)
Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol.Drug and alcohol dependence, 114 2-3
W. Devane, L. Hanuš, A. Breuer, R. Pertwee, L. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, R. Mechoulam (1992)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.Science, 258 5090
P. Sullivan (2007)
Spurious Genetic AssociationsBiological Psychiatry, 61
K. Maclean, John Littleton (1977)
Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol.European journal of pharmacology, 41 2
C. O’Tuathaigh, Magdalena Hryniewiecka, Á. Behan, O. Tighe, C. Coughlan, L. Desbonnet, M. Cannon, M. Karayiorgou, J. Gogos, D. Cotter, J. Waddington (2010)
Chronic Adolescent Exposure to Δ-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Psychosis-Related and Other PhenotypesNeuropsychopharmacology, 35
A. Zuardi, J. Crippa, J. Hallak, S. Bhattacharyya, Z. Atakan, R. Martín-Santos, P. McGuire, F. Guimarães (2012)
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.Current pharmaceutical design, 18 32
P. Stokes, M. Mehta, M. Mehta, H. Curran, G. Breen, P. Grasby (2009)
Can recreational doses of THC produce significant dopamine release in the human striatum?NeuroImage, 48
R. Mechoulam, L. Parker, R. Gallily (2002)
Cannabidiol: An Overview of Some Pharmacological AspectsThe Journal of Clinical Pharmacology, 42
R. Mechoulam, S. Ben-Shabat, L. Hanuš, M. Ligumsky, N. Kaminski, A. Schatz, A. Gopher, S. Almog, B. Martin, D. Compton, R. Pertwee, G. Griffin, M. Bayewitch, J. Barg, Z. Vogel (1995)
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.Biochemical pharmacology, 50 1
B. Gutiérrez, M. Rivera, Lourdes Obel, Kathryn McKenney, R. Martínez-Leal, E. Molina, M. Dolz, S. Ochoa, J. Usall, J. Haro, M. Ruíz-Veguilla, Francisco Torresa, J. Cervilla (2009)
Variability of the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumptionRevista de Psiquiatría y Salud Mental, 2
C. Schubart, M. Boks, E. Breetvelt, W. Gastel, R. Groenwold, R. Ophoff, I. Sommer, R. Kahn (2011)
Association between cannabis and psychiatric hospitalizationActa Psychiatrica Scandinavica, 123
S. Marinelli, Simone Pacioni, A. Cannich, G. Marsicano, A. Bacci (2009)
Self-modulation of neocortical pyramidal neurons by endocannabinoidsNature Neuroscience, 12
T. Rubino, N. Realini, D. Braida, S. Guidi, V. Capurro, D. Vigano', C. Guidali, Marta Pinter, M. Sala, R. Bartesaghi, D. Parolaro (2009)
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthoodHippocampus, 19
Miriam Schneider, E. Schömig, F. Leweke (2008)
PRECLINICAL STUDY: Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult ratsAddiction Biology, 13
A. Verdéjo-Garcia, A. Fagundo, A. Cuenca, Joan Rodríguez, E. Cuyás, K. Langohr, S. Llopis, E. Civit, M. Farré, J. Peña-Casanova, R. Torre (2013)
COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis UsersNeuropsychopharmacology, 38
R. Pertwee (2010)
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.Current medicinal chemistry, 17 14
S. Mato, Vivien Chevaleyre, David Robbe, Á. Pazos, P. Castillo, O. Manzoni (2004)
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticityNature Neuroscience, 7
M. Klugmann, Viktoria Klippenstein, F. Leweke, R. Spanagel, Miriam Schneider (2011)
Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.The international journal of neuropsychopharmacology, 14 4
Jacqueline Stowkowy, J. Addington (2013)
Predictors of a clinical high risk status among individuals with a family history of psychosisSchizophrenia Research, 147
M. Yücel, E. Bora, D. Lubman, N. Solowij, W. Brewer, S. Cotton, P. Conus, M. Takagi, A. Fornito, S. Wood, P. McGorry, C. Pantelis (2012)
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.Schizophrenia bulletin, 38 2
Brad Grueter, Gabor Brasnjo, R. Malenka (2010)
Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbensNature Neuroscience, 13
Miriam Schneider, M. Koch (2003)
Chronic Pubertal, but not Adult Chronic Cannabinoid Treatment Impairs Sensorimotor Gating, Recognition Memory, and the Performance in a Progressive Ratio Task in Adult RatsNeuropsychopharmacology, 28
S. Azad, J. Kurz, G. Marsicano, B. Lutz, W. Zieglgänsberger, G. Rammes (2008)
Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala.Learning & memory, 15 3
M. Bloomfield, M. Bloomfield, C. Morgan, A. Egerton, A. Egerton, S. Kapur, H. Curran, Oliver Howes, Oliver Howes (2014)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic SymptomsBiological Psychiatry, 75
R. Kuepper, J. Os, R. Lieb, H. Wittchen, C. Henquet (2011)
Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort studyPsychological Medicine, 41
J. López-Moreno, G. González-Cuevas, G. Moreno, M. Navarro (2008)
The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addictionAddiction Biology, 13
T. Moore, S. Zammit, A. Lingford-Hughes, T. Barnes, Peter Jones, M. Burke, G. Lewis (2007)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewThe Lancet, 370
Nadia Solowij, Murat Yücel, C. Respondek, Sarah Whittle, E. Lindsay, Christos Pantelis, D. Lubman (2011)
Cerebellar white-matter changes in cannabis users with and without schizophreniaPsychological Medicine, 41
W. Wilson, R. Mathew, T. Turkington, T. Hawk, R. Coleman, James Provenzale (2000)
Brain Morphological Changes and Early Marijuana UseJournal of Addictive Diseases, 19
Amir Englund, P. Morrison, J. Nottage, D. Hague, F. Kane, S. Bonaccorso, J. Stone, A. Reichenberg, R. Brenneisen, D. Holt, A. Feilding, Lucy Walker, R. Murray, S. Kapur (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairmentJournal of Psychopharmacology, 27
R. Murray, P. Morrison, C. Henquet, M. Forti (2007)
Cannabis, the mind and society: the hash realitiesNature Reviews Neuroscience, 8
C. O’Tuathaigh, G. Clarke, J. Walsh, L. Desbonnet, Emilie Petit, C. O’Leary, O. Tighe, Niamh Clarke, M. Karayiorgou, J. Gogos, T. Dinan, J. Cryan, J. Waddington (2012)
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.The international journal of neuropsychopharmacology, 15 9
M. Konings, M. Bak, M. Hanssen, J. Os, L. Krabbendam (2006)
Validity and reliability of the CAPE: a self‐report instrument for the measurement of psychotic experiences in the general populationActa Psychiatrica Scandinavica, 114
A. Egerton, C. Chaddock, T. Winton-Brown, M. Bloomfield, S. Bhattacharyya, P. Allen, P. McGuire, O. Howes (2013)
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second CohortBiological Psychiatry, 74
J. Os, B. Rutten, R. Poulton (2008)
Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.Schizophrenia bulletin, 34 6
Miriam Schneider, M. Koch (2007)
The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesionEuropean Neuropsychopharmacology, 17
R. Kuepper, C. Henquet, R. Lieb, H. Wittchen, J. Os (2011)
Non-replication of interaction between cannabis use and trauma in predicting psychosisSchizophrenia Research, 131
N. Stefanis, P. Delespaul, C. Henquet, C. Bakoula, C. Stefanis, J. Os (2004)
Early adolescent cannabis exposure and positive and negative dimensions of psychosis.Addiction, 99 10
S. Purcell, N. Wray, J. Stone, P. Visscher, M. O’Donovan, P. Sullivan, P. Sklar (2009)
Common polygenic variation contributes to risk of schizophrenia and bipolar disorderNature, 460
H. Ehrenreich, T. Rinn, H. Kunert, M. Moeller, W. Poser, L. Schilling, G. Gigerenzer, M. Hoehe (1999)
Specific attentional dysfunction in adults following early start of cannabis usePsychopharmacology, 142
A. Hoffman, M. Oz, Ruiqin Yang, A. Lichtman, C. Lupica (2007)
Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.Learning & memory, 14 1-2
Nadia Solowij (1995)
Do cognitive impairments recover following cessation of cannabis use?Life sciences, 56 23-24
K. Mackie (2005)
Distribution of cannabinoid receptors in the central and peripheral nervous system.Handbook of experimental pharmacology, 168
C. Schubart, I. Sommer, W. Gastel, R. Goetgebuer, R. Kahn, M. Boks (2011)
Cannabis with high cannabidiol content is associated with fewer psychotic experiencesSchizophrenia Research, 130
C. Henquet, A. Rosa, P. Delespaul, S. Papiol, L. Fañanás, J. Os, J. Os, I. Myin-Germeys, I. Myin-Germeys (2009)
COMT Val158Met moderation of cannabis‐induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily lifeActa Psychiatrica Scandinavica, 119
Jingshan Chen, B. Lipska, N. Halim, Quang Ma, M. Matsumoto, Samer Melhem, B. Kolachana, T. Hyde, M. Herman, J. Apud, M. Egan, J. Kleinman, D. Weinberger (2004)
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.American journal of human genetics, 75 5
L. Arseneault, M. Cannon, R. Poulton, R. Murray, A. Caspi, T. Moffitt (2002)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective studyBMJ : British Medical Journal, 325
J. Arnold, A. Boucher, T. Karl (2012)
The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.Current pharmaceutical design, 18 32
A. Chávez, Chiayu Chiu, P. Castillo (2010)
TRPV1 activation by endogenous anandamide triggers postsynaptic LTD in dentate gyrusNature neuroscience, 13
T. Lundqvist (2005)
Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functionsPharmacology Biochemistry and Behavior, 81
D. Arnone, T. Barrick, S. Chengappa, C. Mackay, C. Clark, M. Abou-Saleh (2008)
Corpus callosum damage in heavy marijuana use: Preliminary evidence from diffusion tensor tractography and tract-based spatial statisticsNeuroImage, 41
M. Yücel, N. Solowij, C. Respondek, S. Whittle, A. Fornito, C. Pantelis, D. Lubman (2008)
Regional brain abnormalities associated with long-term heavy cannabis use.Archives of general psychiatry, 65 6
E. Barkus, P. Morrison, D. Vuletić, J. Dickson, P. Ell, L. Pilowsky, R. Brenneisen, D. Holt, J. Powell, S. Kapur, R. Murray (2011)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET studyJournal of Psychopharmacology, 25
J. Decoster, J. os, I. Myin-Germeys, M. Hert, R. Winkel (2012)
Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions.Current pharmaceutical design, 18 32
R. Pertwee (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 153
S. Alemany, B. Sampériz, E. Martin, J. Higueras, G. Ortet, C. Gastó, Fañanás Saura (2014)
Título artículo / Títol article: Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes
M. Bossong, R. Niesink (2010)
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophreniaProgress in Neurobiology, 92
Epidemiological studies have shown that the association between cannabis and psychosis is robust and consistent across different samples, with compelling evidence for a dose-response relationship. Because longitudinal work indicates that cannabis use precedes psychotic symptoms, it seems reasonable to assume a causal relationship. However, more work is needed to address the possibility of gene-environment correlation (for example, genetic risk for psychosis causing onset of cannabis use). Moreover, knowledge about underlying biological mechanisms linking cannabis use and psychosis is still relatively limited. In order to understand how cannabis use may lead to an increased risk for psychosis, in the present article we ( a ) review the epidemiological, neurobiological, and genetic evidence linking cannabinoids and psychosis, ( b ) assess the quality of the evidence, and finally ( c ) try to integrate the most robust findings into a neurodevelopmental model of cannabis-induced psychosis and identify the gaps in knowledge that are in need of further investigation.
Annual Review of Clinical Psychology – Annual Reviews
Published: Mar 28, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.